Neoleukin Therapeutics, Inc. NLTX NASDAQ

NASDAQ Global Market • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score

30/100

0/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

Stock Statistics — NLTX

Neoleukin Therapeutics, Inc. (NLTX) has a market capitalization of $8.2M and trades at $3.49. The 52-week range is 3.42-18.8.

The stock has a beta of 1.10, operates in the Healthcare sector.

Trading Data

Current Price$3.49

52-Week Range3.42-18.8

Volume109.1K

Avg Volume (30D)5.52K

Market Cap$8.2M

Beta (1Y)1.10

Company

IPO Date2014-03-07

Employees7

CEODonna M. Cochener-Metcalfe

CountryUS

ExchangeNASDAQ Global Market

CurrencyUSD

ISINUS64049K2033

CUSIP64049K104

Income (Latest Year)

EBITDA$-103.33M

Operating Income$-103.33M

Net Income$-90.35M

Balance Sheet (Latest Year)

Total Assets$288.6M

Current Assets$271.77M

Cash & ST Investments$269.01M

Total Liabilities$23.72M

Total Debt$9.89M

Net Debt$-93.95M

Total Equity$264.89M

Debt / Equity0.04

Valuation Ratios

P/B Ratio0.03

People Also View

CytomX Therapeutics, Inc.

$4.54

+3.42%

ASMB

Assembly Biosciences, Inc.

$29.44

+0.68%

SPRO

Spero Therapeutics, Inc.

$2.78

-0.36%

ACHL

Achilles Therapeutics plc

Eli Lilly and Company

$922.50

-0.76%

Neoleukin Therapeutics, Inc. NLTX NASDAQ

Stock Statistics — NLTX

People Also View

Get Undervalued Stock Alerts